AdaptHealth (AHCO) Cash from Investing Activities (2018 - 2026)

AdaptHealth's Cash from Investing Activities history runs 9 years deep, the most recent figure standing at -$204.5 million for Q1 2026.

• On a quarterly basis, Cash from Investing Activities fell 113.9% year-over-year to -$204.5 million in Q1 2026; TTM through Mar 2026 was -$412.1 million, a 29.59% decrease from a year earlier, with the FY2025 full-year figure at -$303.2 million, up 2.28% from the prior year.
• Cash from Investing Activities declined to -$204.5 million in Q1 2026 per AHCO's latest filing, from -$124.5 million in the prior quarter.
• Across five years, Cash from Investing Activities topped out at $9.6 million in Q2 2025 and bottomed at -$204.5 million in Q1 2026.
• The 5-year median for Cash from Investing Activities is -$89.9 million (2022), against an average of -$93.3 million.
• Across the five-year window, Cash from Investing Activities surged 111.82% in 2025 and tumbled 113.9% in 2026, its largest moves.
• Year by year, Cash from Investing Activities stood at -$145.8 million in 2022, then soared by 37.98% to -$90.4 million in 2023, then increased by 3.92% to -$86.9 million in 2024, then sank by 43.28% to -$124.5 million in 2025, then tumbled by 64.26% to -$204.5 million in 2026.
• Per Business Quant, the three latest AHCO Cash from Investing Activities figures stand at -$204.5 million (Q1 2026), -$124.5 million (Q4 2025), and -$92.7 million (Q3 2025).